Pharmacy Practice and Science Department Highlights: June 2022

June 1, 2022
Image
A pharmacist speaking with a patient during a health fair.

(June 1, 2022)

Publications

Outcomes and risk factors for delayed-onset postoperative respiratory failure: a multi-center case-control study by the University of California Critical Care Research Collaborative (UC3RC). BMC Anesthesiology (2022) 22:146

  • Stocking JC.
  • Drake C.
  • Aldrich JM.
  • Ong MK.
  • Amin A.
  • Marmor RA.
  • Godat L.
  • Cannesson M.
  • Gropper MA.
  • Romano PS.
  • Sandrock C.
  • Bime C.
  • Ivo Abraham, PhD, RN
  • Utter GH.

The enemy of your enemy should be your friend: why biosimilar companies should collaborate Center for Biosimilars (2022)

Cost-effectiveness and value of information analyses of bruton’s tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States. Journal of Managed Care and Specialty Pharmacy (2022) 28:390-400.

Differential agnostic effect size analysis of lumbar stenosis surgeries International Journal of Spine Surgery (2022)16:318-342

  • Lewandrowski KU.
  • Ivo Abraham, PhD, RN
  • Ramirez León JF.
  • Soriano Sánchez JA.
  • Dowling A.
  • Hellinger S.
  • Freitas Ramos MR.
  • Teixeira de Carvalho, PS. 
  • Yeung C.
  • Salari N.
  • Yeung A.

Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer in the United States Journal of Managed Care and Specialty Pharmacy (2022) 28:435-448

A differential clinical benefit examination of full lumbar endoscopy vs interspinous process spacers in the treatment of spinal stenosis: an effect size meta-analysis of clinical outcomes International Journal of Spine Surgery (2022) 16:102-123

  • Lewandrowski, KU.
  • Ivo Abraham, PhD, RN
  • Ramirez León, JF.
  • Cantú-Leal, R.
  • Longoria, RC.
  • Soriano Sánchez, JA.
  • Yeung, A.

Association of chemotherapy and subjective cognitive impairment in breast cancer patients: meta-analysis of longitudinal prospective cohort studies European Journal of Oncology Nursing (2022) 57:102099

Journal of Medical Economics in review: the best of 2021 Journal of Medical Economics (2022) 25:282-286

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia Blood Advances (2022) May 9;bloodadvances.2022007673 doi: 10.1182/bloodadvances.2022007673. Online ahead of print.

  • Giles JB.
  • Steiner HE.
  • Rollin J.
  • Shaffer CM.
  • Momozawa Y.
  • Mushiroda T.
  • Inai C.
  • Selleng K.
  • Thiele T.
  • Pouplard C.
  • Heddle NM.
  • Kubo M.
  • Miller EC.
  • Martinez KL.
  • Phillips EJ.
  • Warkentin TE.
  • Gruel Y.
  • Greinacher A.
  • Roden DM.
  • Jason H. Karnes, PharmD, PhD, BCPS, FAHA

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. Blood (2022) Mar 4;blood.2021014240 doi: 10.1182/blood.2021014240. Online ahead of print.

  • Jason H. Karnes, PharmD, PhD, BCPS, FAHA
  • Rollin, J.
  • Giles, JB.
  • Martinez, KL.
  • Steiner, HE.
  • Shaffer, CM.
  • Momozawa, Y.
  • Inai, C.
  • Bombin, A.
  • Shi, M.
  • Mosley, JD.
  • Stanaway, I.
  • Selleng, K.
  • Thiele, T.
  • Mushiroda, T.
  • Pouplard, C.
  • Heddle, NM.
  • Kubo, M.
  • Phillips, EJ.
  • Warkentin, TE.
  • Gruel, Y.
  • Greinacher, A.
  • Roden, DM.

Mining the plasma proteome for insights into the molecular pathology of pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine (2022) Apr 8 doi: 10.1164/rccm.202109-2106OC. Online ahead of print.

  • Harbaum L.
  • Rhodes CJ.
  • Wharton J.
  • Lawrie A.
  • Jason H. Karnes, PharmD, PhD, BCPS, FAHA
  • Desai, AA.
  • Nichols, WC.
  • Humbert, M.
  • Montani, D.
  • Girerd, B.
  • Sitbon, O.
  • Boehm, M.
  • Novoyatleva, T.
  • Schermuly, RT.
  • Ghofrani, HA.
  • Toshner, M.
  • Kiely, DG.
  • Howard, LS.
  • Swietlik, EM.
  • Gräf, S.
  • Pietzner, M.
  • Morrell, NW.
  • Wilkins, MR.

Correlation of self-reported pain severity and healthcare expenditures in older United States adults Scandinavian Journal of Pain (2022) 22(1):133-141. Doi: 10.1515/sjpain-2021-0148

Association of low-income subsidy, Medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries Research in Social and Administrative Pharmacy (2022)18(4):2634-2642. Doi: 10.1016/j.sapharm.2021.05.005.

Investigating prescription medication expenditures and level of perceived health status among older adults with pain in the United States Medicines (2022) 9(3):17. Doi: 10.3390/medicines9030017.

Program of All-inclusive Care for the Elderly (PACE) versus other programs: a scoping review of health outcomes Geriatrics (2022) 7(2):31. Doi:10.3390/geriatrics7020031.

Psychometric evaluation of a comprehensive medication management service experience instrument Journal of the American Pharmacists Association (2022) 62(1):218-223. Doi: 10.1016/j.japh.2021.08.024.

Evaluating students’ COVID-19 knowledge, attitudes, and practices (COVKAP) during the COVID-19 pandemic Pharmacy (2022) 10(2):46. Doi: 10.3390/pharmacy10020046.

Evaluation of a pharmacist-led telephonic medication therapy management program in rural Arizona: implications for community health practice Clinics & Practice (2022) 12(3):243-252. Doi: 10.3390/clinpract12030029.

Identifying predictors of opioid use among older United States’ adults with pain Journal of Opioid Management (2022) 18(2):95-105 . Doi: 10.5055/jom.2022.0700

Key informant perspectives about telephonic comprehensive medication review services in the United States Journal of the American Pharmacists Association (2022) 62(3):817-825. Doi: 10.1016/j.japh.2022.01.006.

Markers of ventricular repolarization and overall mortality in sleep disordered breathing Sleep Medicine (2022) Apr 22;95:9-15

  • Patel, S.I.
  • Zareba, W.
  • Bonnie LaFleur, PhD
  • Couderc, J.P.
  • Xia, X.
  • Woosley, R.
  • Patel, I.Y.
  • Combs, D.
  • Mashaqi, S.
  • Quan, S.F.
  • Parthasarathy, S.

Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells Clinical Cancer Research (2022) 28(8), pp.1701-1711

  • Goff, P.H.
  • Riolobos, L.
  • Bonnie LaFleur, PhD
  • Spraker, M.B.
  • Seo, Y.D.
  • Smythe, K.S.
  • Campbell, J.S.
  • Pierce, R.H.
  • Zhang, Y.
  • He, Q.
  • Kim, E.Y.

NeoScore integrates characteristics of the neoantigen: MHC class I interaction and expression to accurately prioritize immunogenic neoantigens. The Journal of Immunology (2022) 208(7), pp.1813-1827.


Presentations

ALEJANDRO VASQUEZ, PHARMD and P4 student Brad Boskie presented “Identifying Barriers to Vaccination: What is the Correlation Between Receipt of COVID-19 Vaccine and Receipt of an Annual Flu Shot?” at the annual NABP meeting May 21, 2022. The poster was developed in conjunction with Drs. NICOLE HENRY and NANCY ALVAREZ.

Lenny ME, Kopp B, Brian Erstad, PharmD presented “Efficacy of fixed dose hydrocortisone for septic shock in obese and non-obese patients,” presented at the Society of Critical Care Medicine Annual Congress, Virtual Meeting; April 2022.

Devlin J, Train S, Burns K, Massaro A, Vassauer J, Selvan K, Kress J, Brian Erstad, PharmD presented “Physicians’ Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS,” and “Critical care pharmacist attitudes and perceptions of neuromuscular blocker infusions in ARDS,” at the Society of Critical Care Medicine Annual Congress, Virtual Meeting; April 2022.

Jackowenko N, Murata J, Kopp B, Brian Erstad, PharmD presented “Influence of timing and catecholamine requirements on vasopressin responsiveness in septic shock,” presented at the Society of Critical Care Medicine Annual Congress, Virtual Meeting; April 2022.

Brian Erstad, PharmD presented “Patient Safety Go Pro: Medication Safety Monitoring and Process Evaluation,” and “Dosing Strategies for Paralytics in ARDS: Keep It Steady or Time for a Change? Continuous/Flat-Dose Strategies,” at the Society of Critical Care Medicine Annual Congress, Virtual Meeting; April 2022.

Marupuru, S., Roether, A., Guimond, AJ., Stanley, C., Pesqueira, T., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Impact of pharmacist provided MTM services versus no MTM services on clinical outcomes among patients with hypertension, dyslipidemia, and diabetes: A systematic review" at the Academy of Managed Care Pharmacy (AMCP) managed care and specialty pharmacy annual meeting. Chicago, IL, US. March 2022.

Whaley, S., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Factors associated with pneumococcal vaccine uptake among vulnerable populations in the primary care setting" at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting. Washington, DC, US. May 2022.

Choi, BM., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Association between patient-physician communication and perceived mental health status among United States adults with cancer" at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting. Washington, DC, US. May 2022.

Awad, NB., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Factors Associated with Good Mental Health Among US Adults with Arthritis" at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting. Washington, DC, US. May 2022.

Almatruk, Z., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Variables associated with frequent exercise among US adults with asthma" at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting. Washington, DC, US. May 2022.

Obeng-Kusi, M., David Rhys Axon, PhD, MPharm, MS, MRPharmS presented "Comorbidities and perceived health status in persons with cancer: a retrospective analysis of the medical expenditure panel survey (MEPS)" at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting. Washington, DC, US. May 2022. 

Nancy Alvarez, PharmD, BCPS presented “Lessons on Leadership from the Front Lines of Pharmacy" at the American Pharmacists Association Annual Meeting and Exposition, San Antonio, TX.  Mar. 2022

Negrete, MJ., Nancy Alvarez, PharmD, BCPS presented “Strategies to Help Address and Prevent Professional Burnout" at the Western Pharmacy Exchange 2022, California Pharmacists Association, Las Vegas, NV.  Apr. 2022

Kawahara, BI., Nancy Alvarez, PharmD, BCPS presented “Leadership – That’s NOT My Job!” at the Western Pharmacy Exchange 2022, California Pharmacists Association, Las Vegas, NV. Apr. 2022

Nancy Alvarez, PharmD, BCPS presented “Pharmacist’s Fundamental Responsibilities and Rights Year One: A Town Hall" at the American Pharmacists Association Annual Meeting 2022, San Antonio, TX.  Mar. 2022.

Nancy Alvarez, PharmD, BCPS presented “The Privilege of Providing Care at the End of Life” at the 2022 Older Americans’ Month, The University of Arizona Health Sciences Office of Equity, Diversity, and Inclusion, Zoom Platform.  May. 2022.

Nancy Alvarez, PharmD, BCPS, Kirtley, JC., Shaughnessy, AM., Rothholz, MC., Fine, K., Horton, A., Cover, J. presented "Responsibilities and rights of pharmacists for contemporary pharmacy practice" at the National Association of Boards of Pharmacy Annual Meeting, Phoenix, AZ. May 2022

Vazquez, A., Henry, N., Boske, B., Nancy Alvarez, PharmD, BCPS presented "What is the correlation between receipt of a COVID-19 vaccine and receipt of an annual flu shot?" at the National Association of Boards of Pharmacy Annual Meeting, Phoenix, AZ.  May 2022.


Kudos

David Rhys Axon, PhD, MPharm, MS, MRPharmS was a guest presenter at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Fireside Chat, on the topic of: The transition from student life to a professional career in academia.

Nancy Alvarez, PharmD, BCPS served as a panelist for the “Women in Pharmacy Leadership Development Forum.” American Pharmacists Association Foundation Women in Pharmacy Committee.  American Pharmacists Association Annual Meeting 2022, San Antonio, TX Mar. 2022

Nancy Alvarez, PharmD, BCPS was appointed to the American Pharmacists Association Foundation Board of Directors 2022-2025 Society of Pain and Palliative Care Pharmacists Foundation – Founding Board Member

Nancy Alvarez, PharmD, BCPS presented “30-Year Journey to the Center of the Pharmacy Universe.”  Class of 2022, University of Iowa College of Pharmacy, Iowa City, IA.  May 2022